Fishawack Health (FH) – a leading commercialization partner for biopharmaceutical, medical technology, and wellness companies – welcomed the US-based health economics and outcomes research consultancy Policy Analysis Inc. (PAI) as part of the company’s expanding Value, Evidence, and Access (VEA) capability.
Leading life science commercialization partner Fishawack Health acquired PRMA Consulting, a premier global market access and health economics outcomes research (HEOR) consultancy with offices across Europe, Asia, and the United States.
W2O, a leading independent provider of analytics-driven technology-enabled marketing and communications solutions to the healthcare sector, announced the acquisition of Elysia Group, a health economic and outcomes research (HEOR) consulting firm operating in the United States and Asia Pacific.
W2O, a leading independent provider of analytics-driven, technology-enabled marketing and communications solutions to the healthcare sector, announced the acquisition of Discern Health.
EVERSANA announced a partnership with the Institute for Clinical and Economic Review (ICER) to advance standards for the usage of transparent, replicable and robust indirect treatment comparisons in health technology assessments.
EVERSANA, a leading independent provider of commercial services to the life science industry, announced an agreement to acquire Canada-based Cornerstone Research Group Inc.